Detachable Clip-assisted Endoscopic Cyanoacrylate Injection in the Treatment of Gastric Varices

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-01

Study Completion Date

2025-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A single-arm exploratory clinical study design was used to evaluate the safety and efficacy of a "modified sandwich injection" of tissue glue assisted by a detachable clip for the treatment of gastric varicose veins.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Secondary Prophylaxis of Gastric Variceal Bleed

NCT02468206

Gastric Varices

COMPLETED NA

Primary Prophylaxis of Gastric Variceal Bleed

NCT02468180

Gastric Varices

UNKNOWN NA

Acute Gastric Variceal Bleeding: Endoscopic Treatment Versus BRTO

NCT02468167

Gastric Varices

UNKNOWN NA

Balloon-occluded Retrograde Transvenous Obliteration for Gastric Variceal Rebleeding

NCT06106971

Gastric Varices Bleeding Liver Decompensation

UNKNOWN PHASE3

Comparison of Endoscopic Injection of Conventional and Double Doses Cyanoacrylate for Gastric Variceal Hemorrhage

NCT00735358

Gastric Variceal Bleeding

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastric Varices Bleeding

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Detachable Clip-assisted

After the varicose vessel is closed with a removable titanium clamp, the more varicose target vessel is located，After the varicose vessels basically disappeared under the endoscope, the removable titanium clamp was removed

Group Type EXPERIMENTAL

Detachable Clip

Intervention Type OTHER

After the varicose vessels basically disappeared under the endoscope, the removable titanium clamp was removed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Detachable Clip

After the varicose vessels basically disappeared under the endoscope, the removable titanium clamp was removed

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The subject voluntarily signs the informed consent for this experiment; According to clinical manifestation, laboratory examination, imaging examination, or liver biopsy in the diagnosis of liver cirrhosis patients; The endoscopy diagnosed gastric varices (gastroesophageal varices, gastroesophageal varices type 2 or type 1 isolated gastric varices type 1); High risk of gastric varices or has a history of gastric varices bleeding. The initial fluid resuscitation patients before or after the recovery hemodynamic stability; The age of 18 years old or more.

Exclusion Criteria

* \< 18 years old; Regional portal hypertension; Always have a liver transplant, via the jugular intrahepatic portal vein system bypass or splenectomy combined varices cut-out art history; A concurrent hepatorenal syndrome and/or multiple organ failure; Significant impact on survival of malignant tumor; Pregnancy or lactation; A known allergy to iodine.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No